[Progress in hypertension and diabetes mellitus]

Area of Science:

• Cardiology
• Endocrinology
• Pharmacology

Context:

• 2009 saw significant advancements and debates in managing hypertension and diabetes mellitus.
• Key studies like ONTARGET, TRANSCEND, and ACCOMPLISH influenced discussions on blood pressure targets and combination therapies.
• The introduction of direct renin inhibitors marked a novel approach to hypertension treatment.

Purpose:

• To review and synthesize the key findings and ongoing discussions in hypertension and diabetes research from 2009.
• To highlight the impact of major clinical trials on therapeutic strategies.
• To address the evolving understanding of glycemic control in diabetic patients.

Summary:

• The ONTARGET, TRANSCEND, and ACCOMPLISH studies fueled debate regarding maximal blood pressure reduction and optimal combination therapies for hypertension.
• The AVOID and ALLAY studies demonstrated the safety and efficacy of direct renin inhibitors, a new class of antihypertensive drugs.
• Research published in 2009 questioned the benefits of strict glycemic control in diabetic patients, prompting a reevaluation of treatment intensity.
• A consensus document emphasized aggressive risk factor management and minimizing hypoglycemia in high-risk diabetic patients.

Impact:

• These findings and discussions have reshaped clinical guidelines and therapeutic approaches for hypertension and diabetes.
• The evidence supports personalized treatment strategies considering individual patient risk and potential for adverse events.
• Ongoing research continues to refine optimal blood pressure and glycemic targets, balancing efficacy with safety.